Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Association between Hypertriglyceridemic-Waist Phenotype and Metabolic Abnormalities in Hypertensive Adults

고혈압자의 고중성지방혈증-허리 표현형과 대사이상 사이의 연관성

  • Kyung-A SHIN (Department of Clinical Laboratory Science, Shinsung University) ;
  • Myung Shin KANG (Department of Laboratory Medicine, Bundang Jesaeng General Hospital)
  • 신경아 (신성대학교 임상병리과) ;
  • 강명신 (분당제생병원 진단검사의학과)
  • Received : 2023.03.29
  • Accepted : 2023.05.03
  • Published : 2023.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The hypertriglyceridemic-waist (HTGW) phenotype can predict the risk of coronary artery disease. This study evaluated the relationship between the HTGW phenotype and metabolic abnormalities in hypertensive adults. The test was conducted on adult hypertension patients aged 20 or older who underwent health checkups from January 2018 to December 2021 at general hospitals in Gyeonggi Province. The HTGW phenotype was triglyceride ≥150 mg/dL and waist circumference ≥90 cm for men and ≥85 cm for women. The prevalence of the HTGW phenotype in the study subjects was 17.9%. After adjusting for age, gender, and BMI, the odds ratio of the HTGW group was 5.09 (95% confidence interval [CI]: 3.545~7.309) for low HDL-cholesterol, 1.68 (95% CI: 1.176~2.411) for high LDL-cholesterol, was 2.92 (95% CI: 2.009~4.235) for high total cholesterol, 3.39 (95% CI: 2.124~5.412) for diabetes and 1.85 (95% CI: 1.286~2.674) for hyperuricemia compared to the normal triglyceride levels with the normal waist (NTNW) group. The area under curve values of the HTGW phenotype for diagnosing metabolic syndrome were 0.849 for all subjects, 0.858 for men, and 0.890 for women. In conclusion, the HTGW phenotype is closely related to metabolic abnormalities and is a useful indicator for monitoring adult hypertensive patients with metabolic syndrome.

고중성지방혈증-허리(hypertriglyceridemic-waist, HTGW) 표현형은 관상동맥질환 위험을 예측하는 것으로 알려져 있다. 본 연구는 고혈압자를 대상으로 HTGW 표현형과 대사이상 사이의 관련성을 평가하였다. 경기지역 종합병원에서 2018년 1월부터 2021년 12월까지 건강검진을 실시한 20세 이상 성인 고혈압자를 대상으로 단면연구를 시행하였다. HTGW 표현형은 중성지방 농도 ≥150 mg/dL, 허리둘레 남성 ≥90 cm, 여성 ≥85 cm로 정의되었다. 본 연구대상자의 HTGW 표현형 유병률은 17.9%였다. 연령과 성별, 체질량지수를 보정한 후 HTGW군의 위험비는 NTNW군과 비교하여 낮은 고밀도 지단백 콜레스테롤은 5.09 (95% 신뢰구간, 95% confidence interval [95% CI]: 3.545~7.309), 높은 저밀도 지단백 콜레스테롤은 1.68 (95% CI: 1.176~2.411), 높은 총콜레스테롤은 2.92 (95% CI: 2.009~4.235), 당뇨병은 3.39 (95% CI: 2.124~5.412), 고요산혈증은 1.85 (95% CI: 1.286~2.674)이었다. 대사증후군을 진단하기 위한 HTGW 표현형의 곡선하 면적값은 전체 대상자 0.849, 남성 0.858, 여성 0.890로 나타났다. 결론적으로 HTGW 표현형은 대사이상과 밀접한 관련이 있으며, 대사증후군이 있는 성인 고혈압자의 모니터링에 유용한 지표였다.

Keywords

References

  1. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Almeras N, et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation. 2000;102:179-184. https://doi.org/10.1161/01.cir.102.2.179
  2. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39-48. https://doi.org/10.1161/circulationaha.106.675355
  3. Chen S, Guo X, Yu S, Yang H, Sun G, Li Z, et al. Hypertriglyceridemic waist phenotype and metabolic abnormalities in hypertensive adults: a STROBE compliant study. Medicine (Baltimore). 2016;95:e5613. https://doi.org/10.1097/md.0000000000005613
  4. Borruel S, Molto JF, Alpanes M, Fernandez-Duran E, Alvarez-Blasco F, Luque-Ramirez M, et al. Surrogate markers of visceral adiposity in young adults: waist circumference and body mass index are more accurate than waist hip ratio, model of adipose distribution and visceral adiposity index. PLoS One. 2014;9:e114112. https://doi.org/10.1371/journal.pone.0114112
  5. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009;32:1916-1920. https://doi.org/10.2337/dc09-0412
  6. LeBlanc S, Coulombe F, Bertrand OF, Bibeau K, Pibarot P, Marette A, et al. Hypertriglyceridemic waist: a simple marker of high-risk atherosclerosis features associated with excess visceral adiposity/ectopic fat. J Am Heart Assoc. 2018;7:e008139. https://doi.org/10.1161/jaha.117.008139
  7. Ma CM, Wang R, Liu XL, Lu N, Lu Q, Yin FZ. The relationship between hypertriglyceridemic waist phenotype and early diabetic nephropathy in type 2 diabetes. Cardiorenal Med. 2017;7:295-300. https://doi.org/10.1159/000477828
  8. Ding Y, Zhang M, Wang L, Yin T, Wang N, Wu J, et al. Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis. Lipids Health Dis. 2019;18:93. https://doi.org/10.1186/s12944-019-1019-2
  9. Gomez-Huelgas R, Bernal-Lopez MR, Villalobos A, Mancera-Romero J, Baca-Osorio AJ, Jansen S, et al. Hypertriglyceridemic waist: an alternative to the metabolic syndrome? Results of the IMAP study (multidisciplinary intervention in primary care). Int J Obes (Lond). 2011;35:292-299. https://doi.org/10.1038/ijo.2010.127
  10. Zhao K, Yang SS, Wang HB, Chen K, Lu ZH, Mu YM. Association between the hypertriglyceridemic waist phenotype and prediabetes in Chinese adults aged 40 years and older. J Diabetes Res. 2018;2018:1031939. https://doi.org/10.1155/2018/1031939
  11. Chen S, Guo X, Dong S, Yu S, Chen Y, Zhang N, et al. Association between the hypertriglyceridemic waist phenotype and hyperuricemia: a cross-sectional study. Clin Rheumatol. 2017;36:1111-1119. https://doi.org/10.1007/s10067-017-3559-z
  12. Wang W, Shen C, Zhao H, Tang W, Yang S, Li J, et al. A prospective study of the hypertriglyceridemic waist phenotype and risk of incident ischemic stroke in a Chinese rural population. Acta Neurol Scand. 2018;138:156-162. https://doi.org/10.1111/ane.12925
  13. Chen D, Sun H, Lu C, Chen W, Guo VY. The association between hypertriglyceridemic-waist phenotype and chronic kidney disease: a cohort study and meta-analysis. Sci Rep. 2022;12:1935. https://doi.org/10.1038/s41598-022-05806-7
  14. Tian YM, Ma N, Jia XJ, Lu Q. The "hyper-triglyceridemic waist phenotype" is a reliable marker for prediction of accumulation of abdominal visceral fat in Chinese adults. Eat Weight Disord. 2020;25:719-726. https://doi.org/10.1007/s40519-019-00677-w
  15. Diaz-Santana MV, Suarez Perez EL, Ortiz Martinez AP, Guzman Serrano M, Perez Cardona CM. Association between the hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus among adults in Puerto Rico. J Immigr Minor Health. 2016;18:102-109. https://doi.org/10.1007/s10903-014-9985-y
  16. Chen S, Guo X, Yu S, Sun G, Li Z, Sun Y. Association between the hypertriglyceridemic waist phenotype, prediabetes, and diabetes mellitus in rural Chinese population: a cross-sectional study. Int J Environ Res Public Health. 2016;13:368. https://doi.org/10.3390/ijerph13040368
  17. Ren Y, Zhang M, Zhao J, Wang C, Luo X, Zhang J, et al. Association of the hypertriglyceridemic waist phenotype and type 2 diabetes mellitus among adults in China. J Diabetes Investig. 2016;7:689-694. https://doi.org/10.1111/jdi.12489
  18. Ren YC, Liu Y, Sun XZ, Wang BY, Liu Y, Ni H, et al. Prevalence and relationship of hypertriglyceridaemic-waist phenotype and type 2 diabetes mellitus among a rural adult Chinese population. Public Health Nutr. 2019;22:1361-1366. https://doi.org/10.1017/s1368980019000181
  19. Zeng J, Liu M, Wu L, Wang J, Yang S, Wang Y, et al. The association of hypertriglyceridemic waist phenotype with chronic kidney disease and its sex difference: a cross-sectional study in an urban Chinese elderly population. Int J Environ Res Public Health. 2016;13:1233. https://doi.org/10.3390/ijerph13121233
  20. Ramezankhani A, Azizi F, Ghanbarian A, Parizadeh D, Hadaegh F. The hypertriglyceridemic waist and waist-to-height ratio phenotypes and chronic kidney disease: cross-sectional and prospective investigations. Obes Res Clin Pract. 2017;11:585-596. https://doi.org/10.1016/j.orcp.2016.11.003
  21. Janghorbani M, Salamat MR, Aminorroaya A, Amini M. Utility of the visceral adiposity index and hypertriglyceridemic waist phenotype for predicting incident hypertension. Endocrinol Metab (Seoul). 2017;32:221-229. https://doi.org/10.3803/enm.2017.32.2.221
  22. Cabral NA, Ribeiro VS, Franca AK, Salgado JV, Santos AM, Salgado Filho N, et al. Hypertriglyceridemic waist and cardiometabolic risk in hypertensive women. Rev Assoc Med Bras. 2012;58:568-573. https://doi.org/10.1590/s0104-42302012000500014
  23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. https://doi.org/10.1161/01.hyp.0000107251.49515.c2
  24. Moon K, Sung SH, Chang YK, Park IK, Paek YM, Kim SG, et al. The association between apolipoprotein E genotype and lipid profiles in healthy woman workers. J Prev Med Public Health. 2010;43:213-221. https://doi.org/10.3961/jpmph.2010.43.3.213
  25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553. https://doi.org/10.1002/(sici)1096-9136(199807)15:7%3C539::aid-dia668%3E3.0.co;2-s
  26. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285: 2486-2497. https://doi.org/10.1001/jama.285.19.2486
  27. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003;42:247-252. https://doi.org/10.1161/01.hyp.0000085858.66548.59
  28. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2007;75:72-80. https://doi.org/10.1016/j.diabres.2006.04.013
  29. de Cuevillas B, Alvarez-Alvarez I, Riezu-Boj JI, Navas-Carretero S, Martinez JA. The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits. Sci Rep. 2021;11:21859. https://doi.org/10.1038/s41598-021-01343-x
  30. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480. https://doi.org/10.1111/j.1464-5491.2006.01858.x
  31. Ren Y, Luo X, Wang C, Yin L, Pang C, Feng T, et al. Prevalence of hypertriglyceridemic waist and association with risk of type 2 diabetes mellitus: a meta-analysis. Diabetes Metab Res Rev. 2016;32:405-412. https://doi.org/10.1002/dmrr.2725
  32. Bard JM, Charles MA, Juhan-Vague I, Vague P, Andre P, Safar M, et al.; BIGPRO Study Group. Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol. 2001;21:407-414. https://doi.org/10.1161/01.atv.21.3.407
  33. Amini M, Esmaillzadeh A, Sadeghi M, Mehvarifar N, Amini M, Zare M. The association of hypertriglyceridemic waist phenotype with type 2 diabetes mellitus among individuals with first relative history of diabetes. J Res Med Sci. 2011;16:156-164.
  34. Lee BJ, Kim JY. Identification of metabolic syndrome using phenotypes consisting of triglyceride levels with anthropometric indices in Korean adults. BMC Endocr Disord. 2020;20:29. https://doi.org/10.1186/s12902-020-0510-0
  35. Brock CM, King DS, Wofford MR, Harrell TK. Exercise, insulin resistance, and hypertension: a complex relationship. Metab Syndr Relat Disord. 2005;3:60-65. https://doi.org/10.1089/met.2005.3.60
  36. Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19:81-87. https://doi.org/10.1097/med.0b013e3283514e13
  37. Le Brocq M, Leslie SJ, Milliken P, Megson IL. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal. 2008;10:1631-1674. https://doi.org/10.1089/ars.2007.2013